loader from loading.io

In the News... Spray insulin tested, Dexcom T2D sensor submitted, A1C period pads... and more!

Diabetes Connections Type 2

Release Date: 01/19/2024

From Restrictive Diets to Realistic Solutions with Dr. Mike Roussell show art From Restrictive Diets to Realistic Solutions with Dr. Mike Roussell

Diabetes Connections Type 2

What you eat is an important part of managing diabetes. By now, we all know being super restrictive doesn’t work, so let’s talk about some easier ways to work in more healthy foods without turning your life upside down. My guest this week is , an author and nutrition consultant who holds a degree in biochemistry and a PHD in nutrition.  We’ll also define insulin resistance and explain why this is an important part of understanding diabetes. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Please visit our...

info_outline
In the News.. Tandem Mobi released, surprising outcomes for type 2 surgery, exercise and diabetes studies, T1D at the Super Bowl, and more! show art In the News.. Tandem Mobi released, surprising outcomes for type 2 surgery, exercise and diabetes studies, T1D at the Super Bowl, and more!

Diabetes Connections Type 2

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Tandem announces it's taking orders and starting to ship the Mobi pump, Insulet gets European approval for the Abbott Libre integration with Omnipod 5, new study looks at type 2 remission and gastric bypass surgery, one type of medication seems to do a much better job preventing kidney stones in people with type 2, big new grant to look at exercise and type 1 and a look back at diabetes at the Super Bowl. Find out more about  Please visit our Sponsors &...

info_outline
A new CGM made for people with type 2 - Learn about Dexcom's Stelo show art A new CGM made for people with type 2 - Learn about Dexcom's Stelo

Diabetes Connections Type 2

Dexcom is planning a new CGM system called Stelo, aimed at people with type 2 diabetes who don't use insulin. This week, we're talking to the Chief Operating Officer Jake Leach all about this. Dexcom is the leading CGM used with insulin pumps, so this is an interesting new direction for them. What’s the difference between this device and those made for people who dose insulin? plus a lot more information about their existing product lines. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our previous episodes with...

info_outline
Need a CGM? Ask your pharmacist. A new pilot program aims to improve access show art Need a CGM? Ask your pharmacist. A new pilot program aims to improve access

Diabetes Connections Type 2

Getting a CGM is, more and more, becoming a routine part of a diabetes diagnosis. But figuring out if your insurance will pay can be anything but routine. A new pilot program is recruiting pharmacists to be a big part of this process, helping educate patients about their options, even writing prescriptions. Plus, with all the talk about CGM, you may have heard about time in range. What is that and why is it inching out A1C as a gold standard measurement. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. More about ...

info_outline
In the News.. weight loss & cancer study for T2D, new pump submitted, Summer Olympic hopeful with T1D and more! show art In the News.. weight loss & cancer study for T2D, new pump submitted, Summer Olympic hopeful with T1D and more!

Diabetes Connections Type 2

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: a look at how weight loss might lower cancer risk in people with type 2, a new study that says BG spikes are good(?!), Modular Medical submits a new insulin pump the FDA, another look at COVID-19's effects on people with diabetes, a marathoner with type 1 heads to the last trial for this summer's Olympics, and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures Learn more about Here's where...

info_outline
Adjusting to a Type 2 Diabetes Diagnosis - PR Pro Matt Friedman show art Adjusting to a Type 2 Diabetes Diagnosis - PR Pro Matt Friedman

Diabetes Connections Type 2

My guest is Matt Friedman, an expert in public relations who lives with type 2 – we get his take on what’s going on in PR these days – with social media, crisis control, and even CHatGPT and AI – and of course we’ll talk about diabetes, and the bone Matt has to pick with restaurants. I love talking abou technology and the majority of these episodes will be about management tools and techniques, but I’ve also learned that personal stories – talking to people JUST living with diabetes – can be extremely helpful. This episode is one of those people focused ones. We'll also talk...

info_outline
Insulin Use with Type 2 Diabetes: Navigating Solutions, Avoiding Stigma show art Insulin Use with Type 2 Diabetes: Navigating Solutions, Avoiding Stigma

Diabetes Connections Type 2

Let’s talk about using insulin. For some, that can feel like a huge failure or that they have the bad type of diabetes. But sometimes, diet and exercise isn’t enough to manage type 2 diabetes. My guest this week is Dr. Arthi Thangudu and she’s going to talk about how she approaches these conversations with her patients and some of the newer options out there for administering insulin. Also this week, as long as we’re talking about insulin, we’ll define the different kinds. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health...

info_outline
In the News... Spray insulin tested, Dexcom T2D sensor submitted, A1C period pads... and more! show art In the News... Spray insulin tested, Dexcom T2D sensor submitted, A1C period pads... and more!

Diabetes Connections Type 2

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Vertex pauses their stem cell transplantation trials after a patient death, spray insulin is tested, learning more about Dexcom's sensor for type 2, measuring A1C through menstrual blood and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! from extreme temperatures Learn more about Here's where to find us: Learn more about everything at our home page Reach out with questions or comments:...

info_outline
Get Kitchen Confident! The Happy Diabetic's Recipe for Living Well with Type 2 Diabetes show art Get Kitchen Confident! The Happy Diabetic's Recipe for Living Well with Type 2 Diabetes

Diabetes Connections Type 2

When you get a diabetes diagnosis, eating well is usually at the top of the “to-do” list. But then you get home and look around the kitchen and – let’s face it – most of us aren’t sure where to start. What’s easy to cook that will taste good? What will my family actually eat? This week I’m talking to Chef Robert Lewis, who calls himself the happy diabetic. He lives with type 2 and he’ll explain why he started off very unhappy! And what changed.. Also this week, we’re explaining the term post prandial  blood sugar. What does it mean and why is your doctor so concerned...

info_outline
Diabetes + Weight Loss: Inside the new partnership between WeightWatchers and Abbott show art Diabetes + Weight Loss: Inside the new partnership between WeightWatchers and Abbott

Diabetes Connections Type 2

This time of year diets are the center of a lot of conversations. So when I heard WeightWatchers was specifically offering something for people with diabetes, I wanted to learn more. WeightWatchers is teaming up with Abbott to use the Freestyle Libe CGM as part of their newest program. What does really mean for people with type 2? What are they offering and will it make a difference? I’m talking to the Chief Science Officer of WeightWatchers and Chief Medical Officer of Abbott. Also this week, why is the fasting blood glucose test so important? And what are it’s limitations? This podcast...

info_outline
 
More Episodes

It’s In the News, a look at the top stories and headlines from the diabetes community happening now. Top stories this week: Vertex pauses their stem cell transplantation trials after a patient death, spray insulin is tested, learning more about Dexcom's sensor for type 2, measuring A1C through menstrual blood and more!

Find out more about Moms' Night Out 

Please visit our Sponsors & Partners - they help make the show possible!

Edgepark Medical Supplies

Check out VIVI Cap to protect your insulin from extreme temperatures

Learn more about AG1 from Athletic Greens 

Here's where to find us:

Facebook (Group)

Facebook (Page)

Instagram

Twitter

Check out Stacey's books!

Learn more about everything at our home page www.diabetes-connections.com 

Reach out with questions or comments: [email protected]

Episode transcript:

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now.

XX

In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark

XX

Our top story this week…

XX

Vertex Pharmaceuticals, Inc. has paused a study of stem cell–derived, fully pancreatic islet cell replacement therapy (VX-880) following two patient deaths.

Neither death is related to the therapy itself - called VX-880 – according to the company. Vertex says they plan to share full data soon. In the study that was paused, 14 patients with type 1 received infusions of VX-880 and standard immunosuppression. After 90 days, 13 of the patients have an A1C under 7 without using exogenous insulin.

This was the study that made a big splash in the New York Times in late 2021 with the headline “A Cure for Type 1 Diabetes?” and featuring Brian Shelton among others. Shelton is one of the two patients who have died.

 

https://www.medscape.com/viewarticle/vertex-pauses-islet-cell-study-after-patient-deaths-2024a10000oe

XX

Early days but researchers in Norway are testing an insulin body spray.

Patients squirt the insulin directly on to their inner forearm, where skin tends to be thinner, allowing easier absorption. Within minutes, it gets absorbed into the bloodstream.

This joins other research on skin patches packed with micro-needles that punch tiny and reportedly painless holes in the skin to let insulin seep through.

The spray contains insulin and propylene carbonate, a chemical often used in cosmetic skin creams to help them penetrate the outer layers of the skin.

In this case, it’s hoped the chemical — attached to insulin in the spray droplets — will help the hormone seep as far as the tiny blood vessels that lie beneath the surface of the skin, where the hormone will then get absorbed into the bloodstream.

 

InsuLife, the Norwegian company developing the body spray, is setting up a trial involving 12 patients with type 1 diabetes to see how different doses of the spray compare with injected insulin in controlling blood-sugar levels. It is used just before a meal, like injected insulin.

 

The clinical trial was set up after a study involving five people found the spray reduced blood sugar levels by about 20 per cent after a meal.

https://www.dailymail.co.uk/health/article-12965203/insulin-spray-arm-diabetes-jab-Hope-sight-millions.html

XX

The FDA clears the Qvin’s Q-Pad™ A1c Test System which uses menstrual blood to get an A1C result.

The kit is intended for the collection of menstrual blood samples by individuals 18 years of age and older using the Q-Pad, a pad with an embedded blood collection strip (Q-Strip). Each kit includes 2 Q-Pads, a return sample container, and a stamped mailing pouch.

The FDA clearance was based on data from a clinical validation study that included 198 participants. Samples were collected using the Q-Pad Kit and were returned to the laboratory by mail. To provide the reference sample, a venous blood draw was performed on participants by a phlebotomist. An analysis of both samples demonstrated that the clinical performance of the Q-Pad test system in measuring HBA1c was equivalent to the traditional method of blood testing.

https://www.empr.com/home/news/fda-approved-q-pad-test-system-uses-menstrual-blood-to-measure-hba1c/

XX

Learning more about Dexcom’s upcoming CGM designed for people with type 2 who don’t use insulin. It’s to be called Stelo and they’ve submitted to the FDA with an eye on a late summer launch. I was at the announced last June – this is a system that will have very few alerts and alarms.. Stelo looks a lot like the G7 but will have different software and will last for about 15 days per sensor.

https://www.theverge.com/2024/1/11/24034098/dexcom-stelo-cgm-diabetes-health-tech-ces-2024

XX

Tandem Diabetes Care's t:slim X2 Insulin Pump Automated Insulin Delivery System is now the first to incorporate the Abbott FreeStyle Libre 2 Plus Sensor for users in the United States. The FreeStyle Libre 2 Plus sensor is a modified version of the FreeStyle Libre 2 sensor cleared in 2023 by the US Food & Drug Administration for use with automated insulin delivery (AID) systems.

The move follows Tandem's December announcement of integration with the recently available 10-day Dexcom G7 sensor.

https://www.medscape.com/viewarticle/tandem-insulin-pump-system-integrates-libre-sensor-2024a10000iq?form=fpf

XX

If you use Omnipod 5 with an Android, there’s a software update you need to do. The FDA has issued a Class one correction recall. due to a software error that occurs when the user enters a bolus amount less than 1 unit without putting a leading zero before the decimal point.

This recall is not a product removal and users should have already received an alert that won’t let them use the app until they do the software update.

https://www.fda.gov/medical-devices/medical-device-recalls/insulet-corporation-recalls-omnipod-5-android-app-due-software-error#:~:text=Reason%20for%20Recall,zero%20before%20the%20decimal%20point.

XX

 

Embecta continues to move ahead with its insulin patch pump.. submitting a 510(k) premarket filing to the FDA for its proprietary insulin patch pump.

This is a disposable pump for people with type 2 diabetes. It also has a closed-loop version under development to follow. That version features an embedded algorithm that requires Embecta to run a clinical study.

Henry Anhalt, chief medical officer, says nine out of 10 people with diabetes live with type 2 diabetes. However, Anhalt says the majority of automated insulin delivery systems cater to those with type 1 diabetes. Embecta aims to offer more options and tools to the broader diabetes care community, he says.

 

https://www.drugdeliverybusiness.com/embecta-submits-insulin-patch-pump-fda/

XX

Update on insulin prices.. as a few prices changes went into affect at the beginning of the year. So, what took effect this month was that Sanofi followed suit with Eli Lilly and Novo Nordisk to implement this cap on insulin co-pays at $35 that took effect January 1.

And that comes after the provisions of the Inflation Reduction Act capped insulin for people on Medicare at $35. The Medicare cap is automatic and part of policy. For everyone with commercial insurance, the cap is voluntary from the companies. For those without government or private insurance, the picture is more complicated. If your insulin is still more than $35 per month, ask your pharmacist for coupons or check out getinsulin dot org.

https://www.pbs.org/newshour/show/new-law-caps-insulin-prices-for-some-with-diabetes-but-cost-remains-high-for-millions

 

XX

 

 

 

Commercial

XX

XX

Young adults who reported higher stress during their teenage years to adulthood were more likely to have high blood pressure, obesity and other cardiometabolic risk factors than their peers who reported less stress, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

Cardiometabolic risk factors often occur together and are a significant cause of cardiovascular disease. These include obesity, Type 2 diabetes or prediabetes, high cholesterol and high blood pressure, researchers noted.

In 2020, cardiometabolic diseases, including cardiovascular diseases and Type 2 diabetes, were the most prevalent chronic health conditions and collectively accounted for nearly a quarter of all deaths in the U.S., according to the American Heart Association statistics. In 2023, the American Heart Association noted the strong connections among cardiovascular disease, kidney disease, Type 2 diabetes and obesity, and suggested redefining cardiovascular risk, prevention and management.

 

https://finance.yahoo.com/news/childhood-stress-linked-higher-risk-100000670.html

XX

Shout out to NBC News for a great story they did recently on LADA – featuring two women who have both been on this podcast. Dr. Phyllisa DeRoze and Mila Clark were both first misdiagnosed with type 2 before they got a correct diagnosis of LADA. I’ll link up the NBC story along with our chats with both women.. thanks to Mila for giving me a mention as one of the voices in the diabetes community who made her think was she had might not be type 2.. but could be LADA.

https://www.nbcnews.com/health/diabetes/diagnosed-type-2-diabetes-may-different-form-disease-rcna132571

 

 

XX

Join us again soon!